Amelioration of Systemic Amyloidosis by Blocking IL-17A and Not by IL-17F, and Arteriosclerosis by Blocking Both IL-17A and IL-17F in an Inflammatory Skin Mouse Model.

Int J Mol Sci · 2024 · PMC11546614 · PMID 39519167

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

KCASP1Tg mice, the mouse model used in this study, combine the pathogenesis of AD and psoriasis, and it is highly significant to examine the effect of IL-17 deficiency on the suppression of complications in this model.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.